Daniele Alesini

530 total citations
18 papers, 184 citations indexed

About

Daniele Alesini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniele Alesini has authored 18 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniele Alesini's work include Cancer Treatment and Pharmacology (7 papers), Prostate Cancer Treatment and Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Daniele Alesini is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Prostate Cancer Treatment and Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Daniele Alesini collaborates with scholars based in Italy, Russia and Germany. Daniele Alesini's co-authors include Enrico Cortesi, Roberto Iacovelli, Antonella Palazzo, Patrizia Trenta, Giuseppe Naso, Matteo Santoni, Amelia Altavilla, Laura De Marchis, Stefano Cascinu and Claudia Mosillo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Urology.

In The Last Decade

Daniele Alesini

16 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniele Alesini Italy 6 121 74 57 34 23 18 184
Suzette Delaloge France 3 89 0.7× 67 0.9× 62 1.1× 30 0.9× 27 1.2× 3 169
Hongbo Ma China 8 144 1.2× 83 1.1× 60 1.1× 49 1.4× 9 0.4× 21 258
Alastair Mathewson United Kingdom 8 102 0.8× 144 1.9× 66 1.2× 48 1.4× 9 0.4× 12 251
Dexin Dong China 8 92 0.8× 111 1.5× 32 0.6× 53 1.6× 8 0.3× 20 260
Yusuke Takahashi Japan 10 64 0.5× 54 0.7× 88 1.5× 46 1.4× 14 0.6× 37 225
Shogen Boku Japan 7 142 1.2× 52 0.7× 136 2.4× 40 1.2× 30 1.3× 38 223
Sherianne Fish United Kingdom 8 99 0.8× 50 0.7× 112 2.0× 39 1.1× 19 0.8× 9 248
Priyanka Sehgal United States 10 118 1.0× 83 1.1× 39 0.7× 53 1.6× 3 0.1× 16 257
Kevin K. Chang United States 6 202 1.7× 48 0.6× 103 1.8× 22 0.6× 36 1.6× 12 274
Jazmín Calyeca United States 6 160 1.3× 88 1.2× 24 0.4× 35 1.0× 6 0.3× 10 261

Countries citing papers authored by Daniele Alesini

Since Specialization
Citations

This map shows the geographic impact of Daniele Alesini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Alesini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Alesini more than expected).

Fields of papers citing papers by Daniele Alesini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Alesini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Alesini. The network helps show where Daniele Alesini may publish in the future.

Co-authorship network of co-authors of Daniele Alesini

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Alesini. A scholar is included among the top collaborators of Daniele Alesini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Alesini. Daniele Alesini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Botticelli, Andrea, Simone Scagnoli, Simona Pisegna, et al.. (2023). 224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study. ESMO Open. 8(1). 101413–101413.
2.
Botticelli, Andrea, Simona Pisegna, Simone Scagnoli, et al.. (2023). 236P Trastuzumab deruxtecan in Italian real-world experience: Updated analysis from DE-REAL study. ESMO Open. 8(1). 101424–101424. 2 indexed citations
3.
Botticelli, Andrea, Agnese Fabbri, Michela Roberto, et al.. (2022). The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature. Frontiers in Oncology. 12. 797157–797157. 2 indexed citations
4.
5.
Fabbri, Agnese, Andrea Botticelli, Claudia Omarini, et al.. (2019). Efficacy and safety of neoadjuvant chemotherapy plus trastuzumab and pertuzumab in non-metastatic HER2-positive breast cancer in real life: NEOPEARL study. Annals of Oncology. 30. v70–v70.
6.
7.
Alesini, Daniele, Claudia Mosillo, Giuseppe Naso, Enrico Cortesi, & Roberto Iacovelli. (2015). Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma. Therapeutic Advances in Urology. 7(5). 286–294. 5 indexed citations
8.
9.
Caffo, Orazio, Umberto Basso, Gaetano Facchini, et al.. (2014). Activity of subsequent new drugs (NDs) in post-docetaxel (DOC) failure for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): A multicenter Italian experience.. Journal of Clinical Oncology. 32(15_suppl). 5089–5089. 4 indexed citations
10.
Passaro, Antonio, et al.. (2014). Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry. 14(5). 646–650. 11 indexed citations
11.
12.
Bracarda, Sergio, Giuseppe Procopio, Daniele Alesini, et al.. (2014). Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report.. Journal of Clinical Oncology. 32(15_suppl). e16058–e16058. 1 indexed citations
13.
Iacovelli, Roberto, Daniele Alesini, Antonella Palazzo, et al.. (2013). Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials. Cancer Treatment Reviews. 40(2). 271–275. 76 indexed citations
14.
Risi, Emanuela, Roberto Iacovelli, Amelia Altavilla, et al.. (2013). Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney. Urology. 82(2). 382–386. 52 indexed citations
15.
Moscetti, Luca, Fabrizio Nelli, Agnese Fabbri, et al.. (2013). Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study. Investigational New Drugs. 31(4). 1035–1043. 12 indexed citations
16.
Alesini, Daniele, Roberto Iacovelli, Antonella Palazzo, et al.. (2012). Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules. Oncology. 84(2). 92–99. 6 indexed citations
17.
Altavilla, Amelia, Roberto Iacovelli, Giuseppe Procopio, et al.. (2012). Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant. Cancer Biology & Therapy. 13(11). 1001–1008. 7 indexed citations
18.
Moscetti, Luca, Enrico Cortesi, Teresa Gamucci, et al.. (2011). Maintenance treatment with bevacizumab after chemotherapy (CT) plus B in metastatic colorectal cancer: An Italian multicenter retrospective analysis.. Journal of Clinical Oncology. 29(15_suppl). e14043–e14043. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzette Delaloge Breakdown of academic impact, for papers by Hongbo Ma Breakdown of academic impact, for papers by Alastair Mathewson Breakdown of academic impact, for papers by Dexin Dong Breakdown of academic impact, for papers by Yusuke Takahashi Breakdown of academic impact, for papers by Shogen Boku Breakdown of academic impact, for papers by Sherianne Fish Breakdown of academic impact, for papers by Priyanka Sehgal Breakdown of academic impact, for papers by Kevin K. Chang Breakdown of academic impact, for papers by Jazmín Calyeca
Rankless by CCL
2026